-
公开(公告)号：US20200158733A1
公开(公告)日：2020-05-21
申请号：US16614883
申请日：2018-05-18
Applicant: Royal Melbourne Institute of Technology
Inventor： Magdalena PLEBANSKI , Mutsa Tatenda MADONDO
IPC: G01N33/574 , C07K16/28 , G01N33/50
Abstract: The present disclosure is based on detecting CC chemokine receptor 4 (CCR4) expression on T effector cells to diagnostically or prophylactically predict subjects, in particular those with a gynaecological cancer who will respond to treatment with low dose cyclophosphamide.
Search Results
1
records
(took 0.012 seconds)
筛选
AND
AND
过滤
NOT
NOT
Scan to Join
